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Abstract
This prospective multicenter study investigated the association of the course of coagulation abnormalities with
initial computed tomography (CT) characteristics and outcome in patients with isolated traumatic brain injury
(TBI). Patient demographics, coagulation parameters, CT characteristics, and outcome data of moderate and
severe TBI patients without major extracranial injuries were prospectively collected. Coagulopathy was defined
as absent, early but temporary, delayed, or early and sustained. Delayed/sustained coagulopathy was associated
with a higher incidence of disturbed pupillary responses (40% versus 27%; p < 0.001) and higher Traumatic Coma
Data Bank (TCDB) CT classification (5 (2–5) versus 2 (1–5); p= 0.003) than in patients without or with early, but
short-lasting coagulopathy. The initial CT of patients with delayed/sustained coagulopathy more frequently
showed intracranial hemorrhage and signs of raised intracranial pressure (ICP) compared to patients with early
coagulopathy only. This was paralleled by higher in-hospital mortality rates (51% versus 33%; p < 0.05), and
poorer 6-month functional outcome in patients with delayed/sustained coagulopathy. The relative risk for in-
hospital mortality was particularly related to disturbed pupillary responses (OR 8.19; 95% CI 3.15,21.32; p < 0.001),
early, short-lasting coagulopathy (OR 6.70; 95% CI 1.74,25.78; p = 0.006), or delayed/sustained coagulopathy (OR
5.25; 95% CI 2.06,13.40; p = 0.001). Delayed/sustained coagulopathy is more frequently associated with CT ab-
normalities and unfavorable outcome at 6 months after TBI than early, short-lasting coagulopathy. Our finding
that not only the mere presence but also the time course of coagulopathy holds predictive value for patient
outcome underlines the importance of systematic hemostatic monitoring over time in TBI.
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Introduction
Brain tissue injury is associated with the release of ce-rebral tissue factor and alterations in the thrombomo-
dulin-protein C pathway, both contributing to a disparity in
clot formation and lysis (Cohen et al., 2007; Drake et al., 1989;
Goodnight et al., 1974; Morel et al., 2008). The consequent
development of coagulation disturbances in patients with
traumatic brain injury (TBI) is frequently independent of the
presence of extracranial bleeding (Zehtabchi et al., 2008). The
incidence of early coagulopathy as a complication of TBI in
patients without extracranial injuries is estimated at 20–35%,
and is strongly associated with unfavorable outcome (Greu-
ters et al., 2011; Harhangi et al., 2008; Wafaisade et al., 2010).
Moreover, several studies have shown that the number of
patients with isolated TBI-associated coagulopathy increased
in the days following trauma, further contributing to TBI-
related mortality (Carrick et al., 2005; Greuters et al., 2011;).
Although TBI-related coagulopathy is an independent
predictor for unfavorable outcome (Greuters et al., 2011), it is
not included as a prognostic indicator for severe TBI in the
evidence-based guidelines of the Brain Trauma Foundation
(BTF; Chesnut et al., 2000), and recently developed prognostic
models (Perel et al., 2008; Steyerberg et al., 2008). This is partly
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due to the limited number of prospective studies focusing on
coagulopathy in isolated TBI. Although coagulation param-
eters have been proposed as possible predictors of outcome,
they did not contribute to an improved prognostic value
when added to a multifactorial model (van Beek et al., 2007).
Moreover, a large number of investigations only focused on
signs of hemostatic disorders upon emergency department
(ED) admission (Bullock et al., 1996; Harhangi et al., 2008). As
a consequence, data describing the relation of clinical indica-
tors for the severity of TBI and the development of coagulo-
pathy after TBI is limited.
Evidence-based predictors for outcome in patients with TBI
include age, the initial Glasgow Coma Scale (GCS) score, dis-
turbances in pupillary responses, and computed tomography
(CT) abnormalities (Chesnut et al., 2000; Maas et al., 2007;
Marshall et al., 1992). CT imaging of the brain is the current
radiological investigation of choice to detect acute intracranial
abnormalities related to head injury. During the last decade,
distinct cranial CT characteristics predictive for outcome in TBI
patients have been identified, including the Traumatic Coma
Data Bank (TCDB) CT classification, and the presence of in-
traparenchymal contusions, midline shift, or subarachnoid
hemorrhage ( Jacobs et al., 2011;Marshall et al., 1992;Wardlaw
et al., 2002; Vos et al., 2001). The association between intra-
cranial pathology and the development of coagulopathy is,
however, unclear. We therefore investigated whether the ini-
tial presence of specific CT characteristics, such as intracerebral
hemorrhage and signs of raised intracranial pressure (ICP), are
associated with the development of coagulopathy in the first
48 h after trauma. This was addressed by investigating the
incidence and course of coagulopathy in a prospective, mul-
ticenter cohort of patients with isolated TBI, and by exploring
the relation of the development of TBI-associated coagulo-
pathy with initial CT characteristics and outcome.
Methods
Study population
The Prospective Observational COhort study Neuro-
trauma (POCON) study is a multicenter study executed in the
Netherlands. The POCONdatabase includes prospective data
for moderate (GCS score 9–13) and severe (GCS score 3–8) TBI
patients admitted between June 1, 2008 and May 31, 2009 to
the emergency department (ED) of one of the following ACS-
COT level I trauma centers: Radboud University Nijmegen
Medical Center (RUNMC), University Medical Center Gro-
ningen, VU University Medical Center, Academic Medical
Center, and Erasmus Medical Center. Patients were eligible
for study inclusion in case of TBI and an ED admission GCS
score £ 13. For the present study, a selection was made of
patients with isolated TBI, defined as head CT scan-confirmed
brain tissue injury without other major extracranial injuries,
like pelvis or femur fractures, or severe abdominal or thoracic
invasive injuries, as indicated by an extracranial Abbreviated
Injury Scale (AIS) < 3. Exclusion criteria were an extracranial
AIS score ‡ 3, age < 16 years, use of coumarin, liver failure, or
missing coagulation parameters upon ED admission.
The prehospital trauma care system is uniform for all re-
gions in the Netherlands. Ambulance paramedics are edu-
cated in advanced basic life support, including intravenous
access, and oxygen therapy through facemask or bag-valve
ventilation. Dutch ambulance paramedics are not allowed to
perform endotracheal intubation in case of a GCS score of 4 or
more. Additionally, four centrally divided helicopter-based
emergency medical services staffed by anesthesiologists or
trauma surgeons are dispatched to support ambulance para-
medics in severely-injured patients.
Protocol approval and patient consent
The local ethics committee of the coordinating hospital
(RUNMC) approved the study protocol. The other partici-
pating hospitals all provided a feasibility statement. After
discharge, surviving patients or their proxy received a study
information letter inviting patients to contact their local
physician or the study coordinator if they had any objections
against being contacted for follow-up. For follow-up through
telephone interview, verbal informed consent was obtained,
and in case of outcome assessment through postal question-
naires, written informed consent was gained.
Demographic and injury severity variables
Demographic and clinical variables, complications, and
treatment modalities were collected from medical records by
trained research staff affiliated with the trauma centers. The
data were checked for completeness by the study coordinator
and were entered into a Microsoft Access database available
as a stand-alone at each individual study center. Demographic
and injury severity variables included age, gender, Injury Se-
verity Score (ISS), AIS head, extracranial AIS, TCDB classifi-
cation, placement of an ICP catheter, theGCS score at the scene
of the accident and upon ED admission, pupil responses de-
fined as both responding versus 1 or both not responding or
dilated, and day-of-injury alcohol intoxication. TBI severity
was categorized as moderate (GCS 9–13) or severe (GCS 3–8).
CT classification
CT imaging of the head was performed upon ED admission
and scans were assessed by three raters (M.J.C.T.A., B.J., and
P.E.V.) using a standardized data sheet as previously described
( Jacobs et al., 2011). Head CT scans were assessed for the
presence of epidural (EDH), subdural hemorrhage (SDH),
subarachnoid, and intraventricular hemorrhage, and the pres-
ence of parenchymal/hemorrhagic contusion. Volumes of
EDH, SDH, and parenchymal/hemorrhagic contusions were
measured and dichotomized into lesions with a volume
< 25mL or ‡ 25mL, in line with the TCDB CT classification
(Marshall et al., 1990). In addition, status of the ambient cisterns
and the presence of midline shift were assessed. CT character-
istics were further classified as signs of cerebral hemorrhage (all
signs of intracranial bleeding), signs of increased ICP (com-
pression of the ambient cisterns and/or midline shift), and
signs of tissue contusion (parenchymal or hemorrhagic contu-
sion.) The TCDB CT classification includes six categories
ranging from I (no visible injury) to VI (non-surgical evacuated
intracranial mass lesions ‡ 25mL; Marshall et al., 1990,1992).
Coagulation parameters
For this study we registered lactate in mmol/L, blood pH,
hemoglobin in mmol/L, activated partial thromboplastin
time (aPTT), prothrombin time (PT), the International Nor-
malized Ratio (INR) of the PT, and platelet count upon ED
admission and in the first 48 h after trauma. Coagulopathy
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was defined as an aPTT > 40 sec and/or a PT in INR > 1.2,
and/or a platelet count < 120*109 per liter. For the PT, the
reference values of the distinct level I trauma centers were
used. Patients were divided into four groups: (1) patients
without coagulopathy (no coagulopathy); (2) patients with
early coagulation disturbances upon ED arrival that were
normalized in the hours following ED admission (early coa-
gulopathy); (3) patients without early coagulopathy who de-
veloped hemostatic abnormalities after ED admission
(delayed coagulopathy); and (4) patients with early coagula-
tion disturbances that did not normalize within 48 h following
trauma (early + sustained coagulopathy).
Outcome parameters
Outcome parameters included need for transfusion of red
blood cells, fresh frozen plasma or platelets, length of ICU
stay, length of hospital stay, hospital mortality, and the 6-
month Glasgow Outcome Scale Extended (GOSE). The GOSE
is a standardized questionnaire to assess the functional status
of the patient and consists of an 8-point scale ranging from 1
(death) to 8 (full recovery; Wilson et al., 1998).
Statistical analysis
Datawere collected and analyzed using IBM SPSS Statistics
17.0 (IBM, New York, NY). Descriptive statistics included
mean, standard deviation, and median with interquartile
range (ISS, TCDB, and GCS). Data were analyzed by a one-
way analysis of variance (ANOVA) (parametric data), a
Kruskal-Wallis test for three-group comparisons (ordinal
data), or a chi-square test (nominal data). Multinomial logistic
regression was used to investigate the relation between age,
TCDB CT classification, pupillary response, TBI category
(moderate or severe injury) scored at the accident scene, and
either early, short-term coagulopathy or delayed or sustained
coagulopathy within 48 h after the incident with in-hospital
mortality. The Nagelkerke R2 was used to determine the ex-
plained variation in outcome. For all analyses, p < 0.05 was
considered statistically significant.
Results
Clinical characteristics of patients
with TBI-related coagulopathy
The POCON database (n= 508) included 296 patients with
isolated TBI. Seventy-eight cases were excluded due to in-
complete coagulation data in the first 48 h after trauma
(n= 218). The overall incidence of early coagulopathy was
34%. Figure 1 represents the aPTT (panel A), platelet count
(panel B), INR (panel C), and PT (panel D), in 218 patients
with complete coagulation data. In this population, 41% had
no coagulopathy, 10% showed early but transient coagulation
abnormalities, 20% developed delayed coagulopathy, and
29% revealed early and sustained coagulation disturbances. A
marked number of patients developed coagulopathy in the
hours after ED admission, which was characterized by an
FIG. 1. Values for the activated partial thromboplastin time (aPTT; A), platelets (B), International Normalized Ratio (INR;
C), and prothrombin time (PT; D) upon emergency department (ED) admission, and the highest or lowest value in 48 h post-
trauma. Patients were divided into four categories: patients without coagulopathy (no coagulopathy; open squares), patients
with early coagulopathy only (early coagulopathy; closed circles), patients who developed delayed coagulopathy without
signs of early hemostatic disturbances (delayed coagulopathy; open circles), and subjects with early and sustained coagu-
lopathy (closed squares). Values represent mean– standard error of the mean.
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increase in aPTT, INR, and PT and a decrease in platelet count
when compared to ED values.
Table 1 represents the demographic characteristics of pa-
tients with isolated TBI without coagulopathy, with early
short-lasting coagulopathy, or with delayed or sustained
coagulopathy. There was no difference in gender, age, and pH
among groups. Patients with delayed or sustained coagulo-
pathy had higher median AIS head values (5 [4–5]) than pa-
tients with early (4 [3–5]) or no (4 [3–4]) coagulopathy
( p< 0.001). The median GCS score at the accident scene was
similar between groups, whereas the median GCS score upon
hospital admission was lower in patients with delayed or
sustained coagulopathy (3 [3–8]) or early coagulopathy (3
[3–10]) compared to patients without coagulopathy (7 [3–12];
p < 0.001). The median TCDB CT classification was higher in
patients with delayed or sustained coagulopathy (5 [2–5])
compared to subjects with early (2 [1–5]) or no coagulopathy
(1 [1–2]). Disturbed pupillary responses were more frequent
in patients with coagulopathy. In addition, coagulopathy was
associated with slightly lower hemoglobin levels upon ED
admission, but these differences were of no clinical relevance.
Patients without coagulopathy more frequently used alcohol
on the day of injury.
Cranial CT characteristics in early
and delayed coagulopathy
The presence of individual cranial CT characteristics in
the patient subgroups is depicted in Figure 2 (n = 205). In-
terestingly, the CT scans of patients with delayed coagu-
lopathy more frequently revealed SDH, SAH, and lesion
volumes of ‡ 25mL (panels B, C, and E), compared to
patients without and with short-lasting coagulopathy. The
relative numbers of EDH and intraventricular hemorrhage
were similar among groups (panels A and D). Cranial CT
imaging revealed more patients with contusions (panel F),
compressed ambient cisterns (panel G), and a midline shift
(panel H), in patients with delayed/sustained coagulo-
pathy. An ICP catheter was placed in 37% of patients with
TBI-related early coagulopathy compared to 14% of pa-
tients without coagulopathy ( p < 0.001). Table 2 represents
the frequency analysis of signs for cerebral hemorrhage,
parenchymal/hemorrhagic tissue contusion or compression,
or increased ICP in patients without or with delayed/sus-
tained coagulopathy. The incidence of delayed/sustained
coagulopathy was the highest in patients with signs of in-
creased ICP.
Delayed and sustained coagulopathy and outcome
Table 3 represents outcome data for patients without
coagulopathy, with early short-lasting coagulopathy, and
with delayed or sustained coagulopathy (n = 205). Patients
with delayed or sustained coagulopathy more frequently
required blood product transfusion and had a longer ICU
and length of hospital stay than patients without coagulo-
pathy or with early coagulopathy. In-hospital mortality was
higher in patients with delayed or sustained coagulopathy
compared to subjects without coagulopathy or patients with
early coagulopathy only. Long-term functional outcome at 6
months after trauma as measured by the GOSE showed a
favorable outcome profile in patients without hemostatic
disorders (Table 3).
Multinomial regression analysis for in-hospital death in-
cluded the parameters age, TCDB classification, early coagu-
lation disturbances that were normalized after ED admission,
delayed or sustained coagulopathy, pupillary responses, and
GCS score category at the scene of the accident (n = 205). The
odds ratio (OR) for TBI category was not significant. The
relative risk for mortality was highest in patients with a dis-
turbed pupillary response (OR 8.2; 95% CI 3.2,21.3; p< 0.001),
and in patients with early short-lasting coagulopathy (OR 6.7;
95% CI 1.7,25.8; p = 0.006), or delayed or sustained coagulo-
pathy (OR 5.3; 95%CI 2.1,13.4; p= 0.001). TheOR for age and a
higher TCDB score estimated 1.1 (95% CI 1.0,1.1; p < 0.001)
and 1.7 (95% CI 1.3,2.2; p< 0.001), respectively. The Nagelk-
erke R2 for the model was 0.58, with a reported likelihood
ratio v2 of 113.0 ( p < 0.001).
Table 1. Demographics of Patients without Coagulopathy, with Early Short-Lasting
Coagulation Disturbances or with Delayed or Sustained Coagulopathy
No coagulopathy
Early short-lasting
coagulopathy
Delayed or sustained
coagulopathy p Value
n 85 34 99
Males (n) 52 (61%) 21 (62%) 66 (67%) n.s.
Age (y) 48 – 21 54– 25 52 – 21 n.s.
ISS (median) 17 (10–23) 17 (10–25) 25 (16–26) < 0.001
AIS head (median) 4 (3–4) 4 (3–5) 5 (4–5) < 0.001
GCS accident scene (median) 7 (3–10) 7 (4–11) 6 (3–9) n.s.
GCS ED admission (median) 7 (3–12) 3 (3–10) 3 (3–8) < 0.001
TCDB CT classification 1 (1–2) 2 (1–5) 5 (2–5) 0.003
Disturbed pupil response 16% 27% 40% < 0.001
Hemoglobin at ED (mmol/L) 8.4 – 0.8 7.6 – 1.5 7.7 – 1.2 < 0.001
Lactate at ED (mmol/L) 2.7 – 2.3 2.6 – 2.0 2.4 – 2.0 n.s.
pH at ED 7.34 – 0.10 7.33 – 0.08 7.33 – 0.10 n.s.
Alcohol 42% 12% 26% 0.02
Values represent mean – standard deviation, frequencies or median with interquartile range. Data were analyzed by analysis of variance,
Kruskal-Wallis, or chi-square testing. Multi-group comparison p values are shown in the table.
ISS, Injury Severity Score; TCDB, Traumatic Coma Data Bank; GCS, Glasgow Coma Scale; AIS, Abbreviated Injury Scale; ED, emergency
department; CT, computed tomography; n.s., not significant.
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FIG. 2. Cranial computed tomography (CT) findings for patients with or without traumatic brain injury (TBI)-associated
coagulation disorders. Panels represent the presence of epidural hematoma (A), subdural hematoma (B), subarachnoid
hemorrhage (C), intraventricular hemorrhage (D), an intracranial bleeding volume > 25mL (E), brain tissue contusion (F),
compressed ambient cisterns (G), and a midline shift (H). Values represent the relative number of patients for each subgroup.
Data were analyzed by chi-square analysis.
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Discussion
This prospective, multicenter study showed that a large
proportion of patients with isolated TBI developed hemostatic
disturbances, and confirmed an estimated incidence rate of
TBI-related early coagulopathy of 20–35%, as reported by
others (Greuters et al., 2011; Harhangi et al., 2008; Wafaisade
et al., 2010). In addition, an equal proportion of patients de-
veloped late-onset coagulopathy within the first 48 h after
trauma. The relative risk for in-hospital mortality was com-
parable for patients with early short-lasting coagulopathy and
delayed/sustained coagulopathy. However, patients with
delayed or sustained coagulopathy more frequently showed
intracranial hemorrhage and signs of increased ICP. This was
paralleled by a higher risk for blood transfusion and a pro-
longed ICU and hospital stay. Six months after trauma, pa-
tients without coagulopathy or early short-lasting
coagulopathy showed better functional outcomes compared
with patients with delayed/sustained coagulopathy. The
predictive value of coagulopathy for unfavorable outcome
was stronger than the TCDB CT classification.
Although we and others show that the occurrence of coa-
gulopathy in the first 48 h after trauma is independently and
strongly associated with unfavorable outcome in TBI (Carrick
et al., 2005; Greuters et al., 2011; Harhangi et al., 2008; Wa-
faisade et al., 2010; Zehtabchi et al., 2008;), it is not identified
as an independent risk factor for survival (Chesnut et al., 2000;
Perel et al., 2008;Steyerberg et al., 2008). Our study further
provides additional information with respect to the course of
coagulopathy and its relation to initial CT findings in these
patients. Early, but short-lasting coagulopathy was associated
with a similar relative risk for in-hospital mortality compared
to delayed or sustained coagulopathy, but lacks an association
with intracranial pathology and long-term outcome. This
disparity between early transient signs of coagulation dis-
turbances and delayed/sustained coagulopathy may be
related to distinct pathophysiological mechanisms. The
initiation of a cascade of intracerebral and systemic processes
and the pathophysiology underlying coagulopathy in isolated
TBI is, however, complex and multifactorial (Brohi et al.,
2008). The initiation of the procoagulant cascade primarily lies
in the excessive release of tissue factor due to the brain injury
itself. Tissue factor is initially highly expressed by the cortical
parenchyma of the brain, but may subsequently induce sys-
temic activation of the coagulation pathway (Drake et al.,
1989; Goodnight et al., 1974). This may result in the devel-
opment of cerebral microthrombi, disseminated intravascular
coagulation, and consumption coagulopathy (Goodnight
et al., 1974; Hulka et al., 1996; Morel et al., 2008). Others
proposed that mechanisms secondary to brain injury, such as
cerebral hypoperfusion caused by systemic hypotension, lead
to activation of the anticoagulant protein C pathway, and a
rise in plasma thrombomodulin levels (Cohen et al., 2007).
Moreover, overt hyperfibrinolysis due to systemic hypo-
perfusion may increase the risk for delayed or secondary
bleeding (Brohi et al., 2008). Additionally, excessive fluid
Table 3. Outcome Parameters in Patients without Coagulopathy, with Short-Lasting Early
Coagulopathy, and Patients with Delayed or Sustained Coagulopathy
No coagulopathy
Early short-lasting
coagulopathy
Delayed or sustained
coagulopathy
Need for transfusion 13% 10% 41%*,#
ICU stay (days) 4 – 6 4– 4 8– 10*
Length of hospital stay (days) 10 – 14 6– 5 18– 23*,#
In-hospital mortality (n) 12 (14%) 7 (33%) 51 (52%)*,#
6-month GOSE (n; p < 0.01) 69 17 94
Died 12 (17%) 7 (41%) 51 (54%)
Vegetative state 0 (0%) 0 (0%) 0 (0%)
Lower severe disability 2 (3%) 1 (6%) 10 (11%)
Upper severe disability 6 (9%) 0 (0%) 4 (4%)
Lower moderate disability 8 (12%) 2 (12%) 8 (9%)
Upper moderate disability 8 (12%) 2 (12%) 8 (9%)
Good recovery 16 (23%) 1 (6%) 6 (6%)
Restless recovery 17 (24%) 4 (23%) 7 (7%)
*p< 0.05 versus no coagulopathy; # p< 0.05 versus early coagulopathy.
Values represent mean– standard deviation, frequencies, or median with interquartile range.
GOSE, Glasgow Outcome Scale Extended; ICU, intensive care unit.
Table 2. Frequency Analysis for Signs of Cerebral Hemorrhage, Tissue Contusion, or Tissue Compression
in Patients with or without Delayed/Sustained Coagulopathy in Isolated Traumatic Brain Injury
No coagulopathy Delayed/sustained coagulopathy X2
Cerebral hemorrhage 49 (38%) 80 (62%) 13.05*
Tissue contusion 35 (36%) 62 (64%) 9.00*
Increased intracranial pressure 26 (29%) 64 (71%) 22.24*
*p< 0.01.
Value represent frequencies. Data were analyzed by chi-square testing.
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resuscitation to prevent cerebral hypoperfusion may further
contribute to hemodilution with depletion of platelets and
clotting factors (Wafaisade et al., 2010). The pathophysiolog-
ical mechanisms underlying early and transient or delayed/
sustained coagulopathy may therefore be based on an im-
balance between procoagulant and anticoagulant processes in
the cerebral and systemic circulation.
Although we showed that coagulopathy is associated with
unfavorable outcome in isolated TBI, it remains unclear
whether coagulopathy is a primary cause for patientmortality
or is secondary to pathophysiological processes, including
cerebral hemorrhage, contusions, or raised ICP. The present
study demonstrated that intracranial hemorrhage is less fre-
quently observed in patients with early, transient coagulation
disturbances, whereas subarachnoid or intracranial hemor-
rhage and signs of raised ICP frequently paralleled delayed/
sustained coagulopathy. Earlier studies showed that an in-
crease in ICP and consequent cerebral tissue compression and
edemawas associatedwith the development of coagulopathy,
but these studies did not focus on the time course of coagu-
lation disturbances (Barklin et al., 2009; Fleck et al., 1990;
Talving et al., 2009). In an experimental pig model, increased
ICP resulted in acute thrombin generation and shortening of
the prothrombin time (Barklin et al., 2009).
An explanation for the association between TBI-related
cerebral tissue damage and compressionmay be related to the
release of tissue factor from the cortex and adventitial vessel
layers into the systemic circulation (Goodnight et al., 1974;
Fleck et al., 1990; Barklin et al., 2009). However, since cerebral
tissue factor measurements are difficult to perform to confirm
this hypothesis, the development of novel indicators for TBI-
related coagulopathy is warranted.
Head CT imaging plays an important role in the diagnosis of
the injury severity in TBI. In this study we assumed that the
TCDB CT classification as an indicator of the level of injury
severity is associated with the development of coagulopathy
andmortality (Maas et al., 2007;Marshall et al., 1991;Wardlaw
et al., 2002). Although we demonstrated that a higher TCDB
classification score and coagulopathy are both associated with
unfavorable outcome, a specific interaction between CT pa-
rameters may be more predictive for mortality (Maas et al.,
2005; Marshall et al., 1992). Furthermore, regression analysis
revealed that coagulopathy itself is associated with a higher
relative risk for mortality than the TCDB CT classification. This
might suggest that, in addition to the severity of brain injury,
coagulation disorders itself add up to an unfavorable outcome.
Our finding that not only the mere presence but also the
time course of coagulopathy holds predictive value for pa-
tient outcome, underlines the importance of systematic he-
mostatic monitoring over time and the need for development
of treatment strategies for coagulation abnormalities in TBI
patients (Carrick et al., 2005; Lustenberger et al., 2010).
However, this requires closer evaluation of diagnostic tools
and treatment modalities for hemostatic disturbances other
than those that are currently available. In the present study
we used the aPTT, INR, PT, and platelet values for the di-
agnosis and definition of coagulopathy, since rotational
thromboelastometry or thromboelastography was not avail-
able at the time of data collection. Although these parameters
are the most commonly used tests for the detection of he-
mostatic and thrombotic disturbances, they do not elucidate
the mechanisms underling TBI-related coagulopathy. Mon-
itoring of platelet function, clot formation, and fibrinolysis
require additional measurement techniques, such as plate-
let aggregation analysis, rotation thromboelastometry, or
thromboelastography. These novel tests may provide an
important and more detailed alternative for the monitoring
of changes in hemostatic and thrombotic parameters in TBI
(Allard et al., 2009; Levrat et al., 2008; Nekludov et al., 2007;
Rugeri et al., 2007). Furthermore, novel diagnostic tools may
enhance our insight into the contribution of fibrinogen and
platelets to clot formation and fibrinolysis, thereby enhanc-
ing our knowledge about the pathophysiological mecha-
nisms underlying the development of coagulopathy in
isolated TBI. Moreover, the insufficient evidence for the ef-
fectiveness of administration of coagulation factors like
heparin, antifibrinolytics, or recombinant factor VII, as
treatment for TBI-associated coagulopathy, prohibits the
design of an effective therapeutic regimen in these patients
(Pahatouridis et al., 2010; Perel et al., 2010).
Our study is limited by the retrospective retrieval and 48-h
time frame of hemostatic parameters, which resulted in the
exclusion of several cases due to incomplete coagulation pa-
rameters. In addition, there were no data available about pre-
existing hemostatic abnormalities in our trauma population.
Moreover, hemostatic testing differed among participating
hospitals, and included both INR and PT as coagulation pa-
rameters. We were further unable to study the relation of
hemodilution or hypothermia, both well-known influencers
of traumatic coagulopathy, as theywere not included as study
parameters in the present study (Fenger-Eriksen et al., 2009;
Maegele et al., 2007). However, despite the associative nature
of our findings, the prospective character of our investigation
and the focus on early and delayed coagulopathy provided
novel insight into the course of coagulopathy and its relation
to outcome after brain injury.
In conclusion, the present study shows that patients who
develop TBI-related coagulopathy in the absence of extra-
cranial bleeding injury in the days following hospital admis-
sion are at greater risk for unfavorable outcome andmortality.
Our findings suggest that specific CT parameters, including
signs of increased ICP and intracranial hemorrhage, are as-
sociated with delayed or sustained coagulopathy in isolated
TBI. This underlines the need for continuous monitoring of
hemostatic parameters in isolated TBI, as early coagulopathy
may resolve and patients without initial hemostatic disorders
may develop coagulopathy at a later stage.
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